Steris (BSP:S1TE34) Capital Expenditure : R$-1,689.53 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Steris Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Steris's cash flow for capital expenditures for the three months ended in Dec. 2023 was R$-583 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was R$-1,689.53 Mil.

Steris Capital Expenditure Historical Data

The historical data trend for Steris's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Capital Expenditure Chart

Steris Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Capital Expenditure

Get a 7-Day Free Trial

-728.64

-1,048.17

-1,348.27

-1,431.03

-1,885.35

Steris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Capital Expenditure	Get a 7-Day Free Trial															-481.63	-372.15	-323.26	-411.35	-582.76

Steris Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-1,689.53 Mil.

Steris (BSP:S1TE34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (BSP:S1TE34) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

STE:USA

Address

5960 Heisley Road, Mentor, OH, USA, 44060

Website

https://www.steris-ir.com

Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.

Steris (BSP:S1TE34) Headlines

No Headlines